Laparoscopically implanted gastric pacemaker after kidney-pancreas transplantation: treatment of morbid obesity and diabetic gastroparesis.
Combined kidney-pancreas transplantation is the treatment of choice for end-stage diabetic nephropathy. Weight gain post-transplant increases the risk for post-transplant complications and death due to cardiovascular events. Gastric pacemakers have been used for therapy of diabetic gastropathy and for the treatment of moderate morbid obesity. We report a patient who experienced significant weight gain following successful kidney-pancreas transplantation and was thereafter successfully treated for diabetic gastroparesis and morbid obesity by use of a laparoscopically implanted gastric pacemaker.
Bonatti
Hugo
H
Department of General and Transplant Surgery, Medical University Innsbruck, Austria.
Brandacher
Gerald
G
Hoeller
Elisabeth
E
Stelzmueller
Ingrid
I
Mark
Walter
W
Margreiter
Raimund
R
Weiss
Helmut
H
D003922:Diabetes Mellitus, Type 1 / Q000150:complications; D018589:Gastroparesis / Q000209:etiology / Q000628:therapy*; D006801:Humans; D016030:Kidney Transplantation; D010535:Laparoscopy; D008297:Male; D008875:Middle Aged; D009767:Obesity, Morbid / Q000150:complications / Q000628:therapy*; D010138:Pacemaker, Artificial; D016035:Pancreas Transplantation